Skip to content

Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP)

Reducing Decannulation Time in Critically-ill Tracheostomized Patients: Decannulation Capping Trial Protocol vs Frequency Aspiration Protocol (REDECAP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02512744
Acronym
REDECAP
Enrollment
330
Registered
2015-07-31
Start date
2016-05-01
Completion date
2018-05-01
Last updated
2018-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Respiratory Therapy, Tracheostomy

Keywords

Tracheostomy, Decannulation, Adult airway management

Brief summary

Multicenter randomized trial centered on critically-ill tracheostomized patients, comparing two different decannulation protocols: 1. based on capping trials to decide decannulation, 2. based on the aspiration frequency to decide decannulation time. High-flow conditioned oxygen therapy will be applied to all patients through the tracheal cannula. In patients included in the suctioning frequency based protocol along the study period and in patients included in the capping trial protocol along periods out of capping trials.

Interventions

PROCEDUREDecannulation protocol.

Comparison of two different decannulation protocols: one protocol based on capping trial tolerance to decide when to decannulate vs. protocol based on suctioning frequency of respiratory secretions to decide when to decannulate (criteria: ≤2 aspirations every 8 h along 24 consecutive hours).

DEVICEHigh flow conditioned oxygen therapy

High flow conditioned oxygen therapy will be applied during all study period through tracheal cannula in the experimental arm (suctioning frequency based protocol) and during periods out of capping trials in the control arm (capping trials based protocol).

Sponsors

Hospital Virgen de la Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically-ill tracheostomized patients weaned from mechanical ventilation (24 consecutive hours disconnected).

Exclusion criteria

* Patients consedered non-decannulable at time of randomization: 1. unconscious patient (motor component of GCS score \<6 points). 2. Severe swallowing function (based on drink test). 3. Airway patency problem (based of intolerance of occlusion test). 4. Neuromuscular diseases. 5. Patients with a Sabadell score \>2.

Design outcomes

Primary

MeasureTime frameDescription
Decannulation timePatients will be followed for the duration of hospital stay, an expected average of 3 monthsTime since weaning from mechanical ventilation (24 consecutive hours disconnected) to decannulation

Secondary

MeasureTime frameDescription
Intensive Care Unit Lenght of stayPatients will be followed for the duration of ICU stay, an expected average of 2 monthsTime since ICU admission to ICU discharge
Hospital lenght of stayPatients will be followed for the duration of hospital stay, an expected average of 3 monthsTime since hospital admission to hospital discharge
Decannulation failurePatients will be followed for the duration of hospital stay, an expected average of 3 monthsNumber of patients requiring recannulation during hospital stay / number of patients included in the group X 100
Hospital mortalityPatients will be followed for the duration of hospital stay, an expected average of 3 monthsHospital mortality in every study group
Respiratory infectionPatients will be followed for the duration of hospital stay, an expected average of 3 monthsPost-randomization pneumonia and tracheobronchitis rate in every study group
ICU mortalityPatients will be followed for the duration of ICU stay, an expected average of 2 monthsICU mortality in every study group

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026